SCHEMBL4912003

SCHEMBL4912003

COC(=O)c1cc(S(=O)(=O)NCCc2ccc3oc(-c4ccccc4)nc3c2)cc(C)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 12/20 0.48
PTPN5 P54829 12/20 0.48
PTPN2 P17706 11/20 0.48
HSPD1 P10809 3/20 0.43
HSPE1 P61604 3/20 0.43
MAPT P10636 2/20 0.43
KDR P35968 1/20 0.43
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43
NPC1 O15118 2/20 0.42
MAPK1 P28482 1/20 0.42
TP53 P04637 2/20 0.42
S1PR1 P21453 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4909037 0.93 PTPN5 (0.48) PTPN1PTPN5PTPN2HSPD1HSPE1
SCHEMBL4905165 0.91 PTPN5 (0.52) PTPN1PTPN5PTPN2HSPD1HSPE1
SCHEMBL4906124 0.86 PTPN5 (0.50) PTPN1PTPN5PTPN2HSPD1HSPE1
SCHEMBL4897733 0.86 PTPN5 (0.54) PTPN1PTPN5PTPN2HSPD1HSPE1
SCHEMBL4903790 0.85 LMNA (0.52) PTPN1PTPN5PTPN2HSPD1HSPE1
SCHEMBL4906792 0.83 PPARG (0.51) KDM4EMEN1KMT2A
SCHEMBL4904070 0.82 NPC1 (0.52) MAPTKDM4EMEN1HPGDKMT2A
SCHEMBL4904651 0.81 PTPN5 (0.55) PTPN1PTPN5PTPN2HSPD1HSPE1
SCHEMBL4895939 0.80 PTPN5 (0.50) PTPN1PTPN5PTPN2HSPD1HSPE1
SCHEMBL4902834 0.79 KDR (0.40) PTPN1PTPN5PTPN2HSPD1HSPE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD PTPN1 1702/4885PTPN5 1700/4885PTPN2 2168/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD PTPN1 2340/4885PTPN5 2304/4885PTPN2 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.